Moderna Inc (NASDAQ:MRNA)

184.40
Delayed Data
As of 3:21pm ET
 +8.44 / +4.80%
Today’s Change
115.03
Today|||52-Week Range
321.31
-27.40%
Year-to-Date
Company News for Dec 8, 2022
9:31am / Zacks.com - Paid Partner Content
Pfizer (PFE) Seeks FDA Nod for Bivalent COVID Jab in Infants
Dec 06 / Zacks.com - Paid Partner Content
These Top Stocks Are Rebounding: Should You Buy Before 2023?
6:00am / MotleyFool.com - Paid Partner Content
Should Investors Buy Pfizer (PFE) & Moderna (MRNA) Stock for 2023?
Dec 05 / Zacks.com - Paid Partner Content
Bucking the Trend: 3 Stocks Showing Stellar Relative Strength this Week
Dec 07 / Zacks.com - Paid Partner Content
Is Veeva Systems Stock a Buy Now?
Dec 03 / MotleyFool.com - Paid Partner Content
3 High-Yielding Stocks That Are Up 27%-Plus This Year
Dec 07 / MotleyFool.com - Paid Partner Content
Moderna Stock: Buy, Sell, or Hold in 2023?
Dec 01 / MotleyFool.com - Paid Partner Content
Moderna Heads Into 2023 With Several Irons in the Fire
Dec 07 / GuruFocus News - Paid Partner Content
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
Nov 30 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close175.96
Today’s open179.12
Day’s range177.68 - 184.53
Volume111,093
Average volume (3 months)4,770,054
Market cap$70.1B
Data as of 3:21pm ET, 12/08/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-21.79%
Earnings growth (next 5 years)-51.00%
Revenue growth (last year)+2,191.90%
P/E ratio6.6
Price/Sales5.95
Price/Book5.20

Competitors

----
BIIBBiogen-3.75-1.28%
ILMNIllumina Inc+1.56+0.75%
GILDGilead Sciences+1.52+1.73%
Data as of 3:21pm ET, 12/08/2022

Financials

Next reporting dateFebruary 23, 2023
EPS forecast (this quarter)$4.97
Annual revenue (last year)$18.4B
Annual profit (last year)$12.2B
Net profit margin66.27%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts